Oxidative Stress, Glutamate, and Neurodegenerative Disorders
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms—oxidative stress and excessive activation of glutamate receptors—are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and inflammation are early events of neurodegenerative diseases [920,944-957]”
In the citing paper
“lipid peroxidation could be a major feature of ferroptosis in AD”
In the citing paper
“the brain contains the high levels of polyunsaturated fatty acids (PUFAs) in its membrane rich architecture”
In the citing paper
“The pathophysiology of depression is multifactorial and includes changes in brain monoaminergic transmission (e.g., 5-HT, NE, DA), abnormalities in neurotransmitter receptors function (e.g., AC-cAMP pathway), reduced neurotrophic factors (e.g., BDNF), dysregulation of HPA axis (cortisol), increased proinflammatory cytokines (e.g., IL-6, TNF-α, NF-κB), increased NO (e.g., L-arginine-NO-cGMP pathway”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [45]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Research works printed but not linked: 8
- CHAN, P.H., REDUCED NEUROTOXICITY IN TRANSGENIC MICE OVEREXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, STROKE 21: 80 (1990).
- CHOI, D.W., METHODS FOR ANTAGONIZING GLUTAMATE NEUROTOXICITY, CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 2: 105 (1990).
- DICHTER, M, EPILEPSIA 30: S3 (1989).
- HALLIWELL, B, ACTA NEUROLOGICA SCANDINAVICA 80 126: 23 (1989).
- JENNER, P, OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE, ACTA NEUROLOGICA SCANDINAVICA 84: 6 (1991).
- Olney, J. W., Kainic Acid as a Tool in Neurobiology: 95 (1978).
- SIESJO, B. K., CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 1: 165 (1989).
- TELLEZ-NAGEL, I, ADVANCES IN NEUROLOGY 1: 387 (1973).
Cited by
Items 201–300 of 1,019
Chen, H.-M., Wu, Y.-C., Chia, Y.-C., Chang, F.-R., Hsu, H.-K., Hsieh, Y.-C., Chen, C.-C., & Yuan, S.-S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.040 · Cited by 280
Du, Y., Bales, K. R., Dodel, R. C., Hamilton-Byrd, E., Horn, J. W., Czilli, D. L., Simmons, L. K., Ni, B., & Paul, S. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11657 · Cited by 279
Farombi, E. O., & Onyema, O. O. (2006) · Human & Experimental Toxicology · doi:10.1191/0960327106ht621oa · Cited by 278
Metabolic Dysfunction and Oxidative Stress in Epilepsy
Pearson-Smith, J., & Patel, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112365 · Cited by 276
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273
Apoptosis and necrosis: two distinct events induced by cadmium in cortical neurons in culture
López, E., Figueroa, S., Oset‐Gasque, M. J., & González, M. P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705111 · Cited by 273
Abe, K., & Saito, H. (2000) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(200005)14:3<149::aid-ptr665>3.0.co;2-5 · Cited by 270
“Accumulating evidence suggests that cellular stress induced by free radicals is responsible for a variety of CNS neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis, and in pathological conditions such as ischaemia and excitotoxicity (Halloween, 1992; Coyle…”
BackgroundPostischemic hypothermia: A critical appraisal with implications for clinical treatment
Colbourne, F., Sutherland, G., & Corbett, D. (1997) · Molecular Neurobiology · doi:10.1007/bf02740655 · Cited by 269
Gao, Z., Huang, K., & Xu, H. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0761 · Cited by 268
Zhou, J., Liu, R., Kamphorst, W., Hofman, M. A., & Swaab, D. F. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00065.x · Cited by 268
Oxygen free radicals in rat limbic structures after kainate-induced seizures
Bruce, A. J., & Baudry, M. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00218-9 · Cited by 266
Rong, Y., Doctrow, S. R., Tocco, G., & Baudry, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9897 · Cited by 266
Troy, C., Derossi, D., Prochiantz, A., Greene, L., & Shelanski, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00253.1996 · Cited by 265
“Excess glutamate in turn can lead to enhanced levels of intracellular Cazt which, in turn, can activate Ca’+-sensitive forms of NOS and increase NO synthesis ( Coyle and Puttfarcken, 1993 ).”
BackgroundArnold, A. J., Razavieh, A., Nasr, J. R., Schulman, D. S., Eichfeld, C. M., & Das, S. (2017) · ACS Nano · doi:10.1021/acsnano.7b00113 · Cited by 265
Bitanihirwe, B. K. Y., & Cunningham, M. G. (2009) · Synapse · doi:10.1002/syn.20683 · Cited by 265
“A plausible mechanism for GABA cell dysfunction in schizophrenia within amygdalar terminal fields is that abnormally increased amygdalar activity may produce an environment of increased glutamatergic transmission and possibly even oxidative stress (Coyle and Puttfarcken 1993).”
BackgroundJou, M., Peng, T., Reiter, R. J., Jou, S., Wu, H., & Wen, S. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00140.x · Cited by 265
“Glial cells also enhance neuronal survival during pathological conditions such as sepsis and age-related neurodegeneration including Parkinson’s disease and Alzheimer’s disease [1, 56].”
BackgroundUse of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Radad, K., Gille, G., Liu, L., & Rausch, W.-D. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05010x · Cited by 265
Zhu, D., Tan, K. S., Zhang, X., Sun, A. Y., Sun, G. Y., & Lee, J. C.-M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02507 · Cited by 264
“Oxidative stress induced by excess production of reactive oxygen species (ROS) has been implicated in pathologic processes associated with brain injuries and other neurodegenerative diseases (Coyle and Puttfarcken, 1993).”
BackgroundTyrosine Hydroxylase and Parkinson’s Disease
Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263
“tive stress hypothesis of PD (for reviews, see Jenner, 1991; Bondy, 1992; Coyle and Puttfarcken 1993; Ebadi et al., 1996) and its relationship to recently discovered genetic factors in this disease, whereas the reader is referred to general reviews for a discussion of the other theories”
Yokota, T., Igarashi, K., Uchihara, T., Jishage, K.-I., Tomita, H., Inaba, A., Li, Y., Arita, M., Suzuki, H., Mizusawa, H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261456098 · Cited by 261
Veerendra Kumar, M. H., & Gupta, Y. K. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00394-4 · Cited by 261
When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
Ross, C. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90138-8 · Cited by 260
“Oxidative stress may be involved in several forms of cell death (Coyle and Puttfarcken, 1993), either as a pathogenic mechanism or as a signaling pathway to activate other cell death pathways.”
BackgroundALONSO‐ALVAREZ, C., BERTRAND, S., FAIVRE, B., & SORCI, G. (2007) · Functional Ecology · doi:10.1111/j.1365-2435.2007.01300.x · Cited by 258
Mitochondrial involvement and oxidative stress in temporal lobe epilepsy
Rowley, S., & Patel, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.002 · Cited by 258
“Lipid peroxidation occurs when hydrogen is abstracted from polyunsaturated fatty acids by ̇OH [52,53].”
BackgroundBhakat, K. K., Mantha, A. K., & Mitra, S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2198 · Cited by 255
“Moreover, chronic oxidative stress and DNA damage have been implicated in several neurodegenerative diseases, including Parkinson’s (PD), Alzheimer’s (AD), Huntington’s (HD), and amyotrophic lateral sclerosis (ALS) (8, 22).”
Fang, J., Nakamura, T., Cho, D.-H., Gu, Z., & Lipton, S. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705904104 · Cited by 255
Reactive oxygen species and oxidative DNA damage.
Hemnani, T., & Parihar, M. S. (1998) · PubMed · Cited by 320
Controversies surrounding glucocorticoid-mediated cell death in the hippocampus
Reagan, L. P., & McEwen, B. S. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00031-8 · Cited by 254
Wang, X., Li, P., Ding, Q., Wu, C., Zhang, W., & Tang, B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11414 · Cited by 254
Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem
Ramanathan, L., Gulyani, S., Nienhuis, R., & Siegel, J. M. (2002) · Neuroreport · doi:10.1097/00001756-200208070-00007 · Cited by 254
Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Gao, X., Kim, H. K., Mo Chung, J., & Chung, K. (2007) · Pain · doi:10.1016/j.pain.2007.01.011 · Cited by 253
“…conditions such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as brain dysfunction due to injury or aging (Olanow, 1992; Coyle and Puttfarcken, 1993; Balazs and Leon, 1994; Gerlach et al., 1994; Jenner, 1994; Hensley et al., 1997; Lewen et al., 2000).”
BackgroundMetalloporphyrin class of therapeutic catalytic antioxidants
Patel, M., & Day, B. J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01336-x · Cited by 253
Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., & Collen, D. (1999) · Circulation · doi:10.1161/01.cir.99.18.2440 · Cited by 252
“Conclusions—Plg system components affect FCI at 2 different levels: (1) reduction of tPA activity ( tPAgene inactivation) reduces whereas its augmentation ( PAI-1 gene inactivation) increases infarct size, and (2) reduction of Plg activity ( Plg gene inactivation ora2-AP injection) increases whereas its augmentation (…”
BackgroundKim, G. W., Kondo, T., Noshita, N., & Chan, P. H. (2002) · Stroke · doi:10.1161/hs0302.103745 · Cited by 251
Yu, D.-Y., Cringle, S. J., Balaratnasingam, C., Morgan, W. H., Yu, P. K., & Su, E.-N. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.07.001 · Cited by 249
Tyurin, V. A., Tyurina, Y. Y., Borisenko, G. G., Sokolova, T. V., Ritov, V. B., Quinn, P. J., Rose, M., Kochanek, P., Graham, S. H., & Kagan, V. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752178.x · Cited by 249
Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain
Yoo, S.-E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., & Ran, Q. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.043 · Cited by 248
Perineuronal nets potentially protect against oxidative stress
Morawski, M., Brückner, M. K., Riederer, P., Brückner, G., & Arendt, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.017 · Cited by 246
Loss of the ataxia–telangiectasia gene product causes oxidative damage in target organs
Barlow, C., Dennery, P. A., Shigenaga, M. K., Smith, M. A., Morrow, J. D., Roberts, L. J., Wynshaw-Boris, A., & Levine, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9915 · Cited by 246
Erickson, J. C., Hollopeter, G., Thomas, S. A., Froelick, G. J., & Palmiter, R. D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01271.1997 · Cited by 246
“cies generated during intense excitation (Coyle and Puttfarcken, 1993).”
Type and Severity of Cognitive Decline in Older Adults after Noncardiac Surgery
Price, C. C., Garvan, C. W., & Monk, T. G. (2008) · Anesthesiology · doi:10.1097/01.anes.0000296072.02527.18 · Cited by 246
Bioenergetics and glutamate excitotoxicity
Greene, J. G., & Greenamyre, J. T. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00006-8 · Cited by 245
Oxidative damage in mild cognitive impairment and early Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245
“George-Hyslop, 1994), the amyloid cascade hypothesis (Selkoe, 1991), trace element toxicity (Markesbery and Ehmann, 1994), mitochondrial defects (Wallace, 1992), and the oxidative stress hypothesis (Coyle and Puttfarcken, 1993).”
BackgroundDubois-Dauphin, M., Frankowski, H., Tsujimoto, Y., Huarte, J., & Martinou, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3309 · Cited by 245
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243
“This vulnerability can be explained by its high content of easily peroxidizable unsaturated fatty acids, the high number of neuronal mitochondria implicating high oxygen consumption rate, and relative paucity of antioxidant enzymes in comparison with other organs [1, 18, 19].”
BackgroundIs multiple sclerosis a mitochondrial disease?
Mao, P., & Reddy, P. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.002 · Cited by 243
“The PLP (139) (140) (141) (142) (143) (144) (145) (146) (147) (148) (149) (150) (151) MAPs were very efficient agents in preventing the development of clinical disease when administered after immunization.”
Taurine and neural cell damage
Saransaari, P., & Oja, S. S. (2000) · Amino Acids · doi:10.1007/s007260070003 · Cited by 243
“Free radicals and excitatory amino acids thus cooperate in the genesis of ischemia-induced neuronal damage (Halliwell and Gutteridge, 1985; Pellegrini-Giampietro et al., 1990; Coyle and Puttfarcken, 1993).”
BackgroundMarkers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia
Tsai, G., Goff, D. C., Chang, R. W., Flood, J., Baer, L., & Coyle, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1207 · Cited by 243
Self-citationKunz, M., Gama, C. S., Andreazza, A. C., Salvador, M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 242
“During periods of high neuronal activity, a significant volume of oxygen is used to maintain neuronal membrane potentials, which subsequently may produce excessive ROS (Chance et al., 1979; Coyle and Puttfarcken, 1993).”
BackgroundPark, D. S., Morris, E. J., Stefanis, L., Troy, C. M., Shelanski, M. L., Geller, H. M., & Greene, L. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-03-00830.1998 · Cited by 239
“Evidence has been presented for the role of peroxynitrite in neurodegenerative disorders, and so the mechanism by which this agent results in apoptosis is of both basic and clinical relevance (Coyle and Puttfarcken , 1993).”
BackgroundSeizures and neuronal damage in mice lacking vesicular zinc
Cole, T. B., Robbins, C. A., Wenzel, H. J., Schwartzkroin, P. A., & Palmiter, R. D. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00121-7 · Cited by 237
Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells
Fukui, M., Song, J.-H., Choi, J., Choi, H. J., & Zhu, B. T. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.059 · Cited by 236
Iron and neurodegenerative disorders
Thompson, K. J., Shoham, S., & Connor, J. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00510-x · Cited by 235
El-Remessy, A. B., Khalil, I. E., Matragoon, S., Abou-Mohamed, G., Tsai, N.-J., Roon, P., Caldwell, R. B., Caldwell, R. W., Green, K., & Liou, G. I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63558-4 · Cited by 235
“This in turn leads to activation of nitric oxide synthase and excess accumulation of superoxides and nitric oxide (NO), causing lipid peroxidation, mitochondrial dysfunction, DNA damage, and the eventual cell death.(5,6) Elevated glutamate levels have been found in the vitreous of glaucomatous patients and monkeys wit…”
BackgroundFamilial amyotrophic lateral sclerosis
Hand, C. K., & Rouleau, G. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10001 · Cited by 235
“Oxidative stress is defined as the cytotoxic consequences of oxygen radicals, superoxide anion (O2 ), hydroxyl radical ( OH), and hydrogen peroxide (H2O2), which are generated in normal metabolism of molecular oxygen.(64) The brain derives almost all its energy from oxidative metabolism of the mitochondrial respirator…”
BackgroundInfluentialNakajima, Y., Shimazawa, M., Mishima, S., & Hara, H. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.09.017 · Cited by 235
Role of melatonin in neurodegenerative diseases
Srinivasan, V., Pandi-Perumal, S. R., Maestroni, G. J. M., Esquifino, A. I., Hardeland, R., & Cardinali, D. P. (2005) · Neurotoxicity Research · doi:10.1007/bf03033887 · Cited by 235
“Kainic acid (KA), an agonist at ionotropic glutamate receptors, administered to rats causes severe brain damage and induces neuronal damage by causing excessive release of glutamate (Coyle and Puttfarcken, 1993; Lipton and Rosenberg, 1994).”
BackgroundStackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230
Qin, Z.-H., Chen, R.-W., Wang, Y., Nakai, M., Chuang, D.-M., & Chase, T. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04023.1999 · Cited by 230
Evaluation of antioxidant activity and total phenol in different varieties of Lantana camara leaves
Kumar, S., Sandhir, R., & Ojha, S. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-560 · Cited by 229
Bellisle, F. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00043-8 · Cited by 229
Mahadik, S. P., Evans, D., & Lal, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00181-0 · Cited by 229
Methylmercury alters glutamate transport in astrocytes
Aschner, M. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00023-1 · Cited by 229
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Kimura, H., Nagai, Y., Umemura, K., & Kimura, Y. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.795 · Cited by 227
The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System
Zeldich, E., Chen, C.-D., Colvin, T. A., Bove-Fenderson, E. A., Liang, J., Tucker Zhou, T. B., Harris, D. A., & Abraham, C. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567321 · Cited by 226
“L-Glutamate, the major excitatory neurotransmitter in the central nervous system (CNS) (4), is neurotoxic at high concentrations due to increases in intracellular calcium levels and enhanced formation of ROS, causing the oxidative stress that contributes to neurodegeneration (5, 6).”
BackgroundGlutathione depletion and oxidative stress
Mytilineou, C., Kramer, B. C., & Yabut, J. A. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00018-4 · Cited by 223
“[10] Coyle JT, Puttfarcken P.”
BackgroundRole of reactive oxygen species in hippocampal long‐term potentiation: Contributory or inhibitory?
Knapp, L. T., & Klann, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10371 · Cited by 223
“XO is an enzyme that is proteolytically derived from the ubiquitously expressed enzyme xanthine dehydogrenase (XD), and the proteolytic cleavage of XD to XO has been proposed to be both glutamate- and calcium-dependent (Coyle and Puttfarcken, 1993).”
BackgroundHazarika, A., Sarkar, S. N., Hajare, S. W., Kataria, M., & Malik, J. K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00574-7 · Cited by 243
Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
“The vulnerability of neurons to the oxidative damage stems also from a relatively large amount of redox active metals, promoting ROS formation, high content of polyunsaturated fatty acids (PUFA), which are more sensitive to oxidation, and from comparatively modest levels of antioxidant enzymes [42].”
BackgroundGlucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro
Behl, C. (1997) · Endocrinology · doi:10.1210/en.138.1.101 · Cited by 220
“Free radicals and oxidative stress-induced neuronal cell death have been implicated in various neurological disorders, such as Parkinson’s disease andAD (29, 30).”
BackgroundBolea, I., Juárez-Jiménez, J., de los Rı́os, C., Chioua, M., Pouplana, R., Luque, F. J., Unzeta, M., Marco-Contelles, J., & Samadi, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200853t · Cited by 219
Lazaroids improve the survival of grafted rat embryonic dopamine neurons.
Nakao, N., Frodl, E. M., Duan, W. M., Widner, H., & Brundin, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12408 · Cited by 219
Homocysteine and Neurologic Disease
Diaz-Arrastia, R. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1422 · Cited by 218
“Importantly, some of these toxic products are also believed to play a role in the pathogenesis of neurodegenerative diseases.(41) Of particular importance to neurologic disease is that homocysteine(42) and its metabolite homocysteic acid(43) are potent agonists for N-methyl-D-aspartate receptors and are neurotoxic to…”
BackgroundKeller, J. N., & Mattson, M. P. (1998) · Reviews in the Neurosciences · doi:10.1515/revneuro.1998.9.2.105 · Cited by 217
How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death
Maher, P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-02929.2001 · Cited by 216
Contestabile, A. (2002) · The Cerebellum · doi:10.1080/147342202753203087 · Cited by 215
“neuropathologies of both the acute and the chronic type.(193,194) Excitotoxicity-based paradigms of neurode-”
Bourdel-Marchasson, I. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.235 · Cited by 215
Oxidative stress and neurodegenerative disorders
Sun, A. Y., & Chen, Y.-M. (1998) · Journal of Biomedical Science · doi:10.1007/bf02255928 · Cited by 215
Differential Sensitivity of RecombinantN-Methyl-d-Aspartate Receptor Subtypes to Zinc Inhibition
Chen, N., Moshaver, A., & Raymond, L. A. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.1015 · Cited by 214
“populations (10, 11); thus, endogenous modulators of NMDA”
BackgroundAntioxidative and Anti‐Inflammatory Protection of Oleanolic Acid and Ursolic Acid in PC12 Cells
Tsai, S., & Yin, M. ‐. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.00864.x · Cited by 214
Neuronal protection and destruction by NO
Lipton, S. A. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400580 · Cited by 214
Ca2+-dependent proteases in ischemic neuronal death
Yamashima, T. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.03.001 · Cited by 213
“For instance, in the ischemic core, caspases are inactivated because of the rapid ATP depletion, impairment of the intracellular ion composition, massive production of nitric oxide or superoxide radicals as well as calpain activation [22] [23] [24] [25] [26] [27] [28].”
BackgroundOxidative Mechanisms and Tardive Dyskinesia
Lohr, J. B., Kuczenski, R., & Niculescu, A. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00004 · Cited by 213
“anisms for neuronal degeneration, many of which interact with one another (including excitotoxicity and other mechanisms,[14] which are reviewed in”
BackgroundFucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway
Kim, K.-N., Heo, S.-J., Kang, S.-M., Ahn, G., & Jeon, Y.-J. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.05.023 · Cited by 213
Zhang, Y., & Bhavnani, B. R. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-49 · Cited by 212
“Background High concentrations (mM) of the excitatory neurotransmitter glutamate can accumulate in the brain and are thought to be involved in the etiology of a number of neurodegenerative disorders including Alzheimer's disease [1,2].”
Chandrasekharan, B., Anitha, M., Blatt, R., Shahnavaz, N., Kooby, D., Staley, C., Mwangi, S., Jones, D. P., Sitaraman, S. V., & Srinivasan, S. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01611.x · Cited by 211
“Experimental evidence supports the notion that oxidative stress is a causal or contributing factor in neurodegenerative disorders (6,7,8,9).”
BackgroundAmyloid β-protein toxicity and oxidative stress in Alzheimer's disease
Behl, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050955 · Cited by 211
“Such an imbalance may ulti- mately lead to free-radical accumulation and to oxidative damage downstream and is defined as oxidative stress (for reviews, see Ames et al. 1993; Coyle and Puttfarcken 1993).”
BackgroundInfluentialNeurotoxicity associated with neuroleptic-induced oral dyskinesias in rats
Andreassen, O. A., & Jørgensen, H. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00064-7 · Cited by 211
Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease
Gordon, T., Hegedus, J., & Tam, S. L. (2004) · Neurological Research · doi:10.1179/016164104225013806 · Cited by 209
Circuits and systems in stress. I. Preclinical studies
Vermetten, E., & Bremner, J. D. (2002) · Depression and Anxiety · doi:10.1002/da.10016 · Cited by 209
“…situations of severe stress, and subsequent glutamatergic neuronal stimulation increase the production of reactive oxygen species, which, through the process of oxidative stress, induces excitotoxicity and neuronal damage [Coyle and Puttfarcken 1993; Savolainen et al., 1995; Nicotera et al., 1997].”
Neurotransmitters and vulnerability of the developing brain
Johnston, M. V. (1995) · Brain and Development · doi:10.1016/0387-7604(95)00079-q · Cited by 209
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Berberine and neurodegeneration: A review of literature
Ahmed, T., Gilani, A.-U.-H., Abdollahi, M., Daglia, M., Nabavi, S. F., & Nabavi, S. M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.002 · Cited by 207
“To date, there are several scientific evidences regarding other molecular pathways which have important roles in the pathophysiology of Parkinson’s disease, such as membrane NADPH oxidases, cytosolic flavoproteins and nitric oxide (as an important contributors of protein dysfunction and cell death) [12].”
BackgroundInfluentialVergun, O., Keelan, J., Khodorov, B. I., & Duchen, M. R. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0451m.x · Cited by 207
“Indeed, there is growing evidence to implicate the generation of free radicals, including nitric oxide (NO), peroxynitrite and superoxide anion in glutamate toxicity (Coyle & Puttfarcken, 1993; Bindokas, 1996; Kashii et al. 1996).”
BackgroundAstrocytes prevent neuronal death induced by reactive oxygen and nitrogen species
Tanaka, J., Toku, K., Zhang, B., Ishihara, K., Sakanaka, M., & Maeda, N. (1999) · Glia · doi:10.1002/(sici)1098-1136(199911)28:2<85::aid-glia1>3.0.co;2-y · Cited by 221
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205
“Glutamate is often described as the primary excitatory neurotransmitter in the brain and may be present in up to 80% of all synapses (Greenamyre et al., 1988; Coyle and Puttfarcken, 1993; Moghaddam and Adams, 1998b; Tapia et al., 1999; Marino et al., 2001; Franks et al., 2002; Javitt et al., 2011), yet we are only now…”
BackgroundInfluentialBehr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice
Amin, F. U., Shah, S. A., & Kim, M. O. (2017) · Scientific Reports · doi:10.1038/srep40753 · Cited by 204
Metadata
- Authors
- Coyle, J. T., & Puttfarcken, P.
- Affiliations
- Harvard University (US)
- ORCID
- Coyle, Joseph T.
- Venue
- Science
- Published
- 1993-10-29
- Volume
- 262
- Issue
- 5134
- Pages
- 689-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016293448
- Cited by
- 3,762
- References
- 104
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 56 · 2023: 58 · 2022: 51 · 2021: 66 · 2020: 74 · 2019: 83 · 2018: 89 · 2017: 104 · 2016: 105 · 2015: 99 · 2014: 158 · 2013: 126 · 2012: 137
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, glutamate, neurodegenerative diseases, glutamate receptors, excitotoxicity, glutamatergic neurotransmission, neurodegeneration, stroke, traumatic brain injury, seizures, selective neurodegeneration, acidic amino acids
- MeSH terms
- Animals, Brain, Glutamates, Humans, Nervous System Diseases, Reactive Oxygen Species, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.